West Pharmaceutical Services (WST) Net Margin (2009 - 2026)
West Pharmaceutical Services (WST) posted quarterly Net Margin of 16.96% for Q2 2026, up 41.0% year-on-year from 12.02% in Q2 2025, and up 5.8% on a QoQ basis from 16.03% in Q1 2026.
West Pharmaceutical Services (WST) Net Margin (2009 - 2026) Analysis & Trends
West Pharmaceutical Services (WST) has reported Net Margin for 18 consecutive years, with 16.96% the latest figure, recorded in Q2 2026.
- Quarterly Net Margin rose 41.0% year-over-year to 16.96% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 16.51% (up 52.0% YoY) and the FY2025 annual result came in at 15.59%, down 93.0% from the prior year.
- Net Margin advanced to 16.96% in Q2 2026 per WST's latest filing, from 16.03% in the prior quarter.
- Over the last five years, Net Margin for WST reached as high as 23.73% in Q2 2022 and fell as low as 12.38% in Q1 2025.
- A 5-year average of 17.6% and a median of 17.03% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin plunged 708 bps — and 2023, when it soared 423 bps.
- Year by year, Net Margin stood at 14.08% in 2022, then grew by 30 bps to 18.27% in 2023, then slipped by 6 bps to 17.11% in 2024, then retreated by 7 bps to 15.93% in 2025, then climbed by 6 bps to 16.96% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 16.96%, 16.03%, and 15.93% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 824.28% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 28.46% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -5.81% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 3.25% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 27.86% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 16.96% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -7.20% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 0.65% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 10.84% |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 0.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.96% |
| Mar 31, 2026 | 16.03% |
| Dec 31, 2025 | 15.93% |
| Sep 30, 2025 | 17.14% |
| Jun 30, 2025 | 16.54% |
| Mar 31, 2025 | 12.38% |
| Dec 31, 2024 | 17.11% |
| Sep 30, 2024 | 17.69% |
| Jun 30, 2024 | 15.21% |
| Mar 31, 2024 | 15.96% |
| Dec 31, 2023 | 18.27% |
| Sep 30, 2023 | 21.09% |
| Jun 30, 2023 | 19.91% |
| Mar 31, 2023 | 18.74% |
| Dec 31, 2022 | 14.08% |
| Sep 30, 2022 | 16.86% |
| Jun 30, 2022 | 23.73% |
| Mar 31, 2022 | 23.14% |
| Dec 31, 2021 | 20.21% |
| Sep 30, 2021 | 23.93% |